Clinical Trial

A Phase III Clinical Study to Evaluate the Efficacy and Safety of MH004 Ointment in Non-segmental Vitiligo

Name: A Phase III Clinical Study to Evaluate the Efficacy and Safety of MH004 Ointment in Non-segmental Vitiligo — clinical trial record (NCT07682506)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This is a randomized, double-blind, multicenter, placebo-controlled clinical study intended to evaluate the efficacy, safety and population pharmacokinetic profiles of MH004 ointment in eligible participants with NSV.

Protocol Amendment History 1 change

critical Recruitment opened 2026-08-12

Trial Details

NCT Number	NCT07682506
Lead Sponsor	Minghui Pharmaceutical (Hangzhou) Ltd
Conditions	Vitiligo
Enrollment	405 participants
Start Date	2026-08-04
Primary Completion	2028-02-23 (estimated)
Study Completion	2028-10-04 (estimated)
Updated on ClinicalTrials.gov	2026-08-11